SBI Securities’s GlucoTrack GCTK Stock Holding History

SBI Securities’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Hold	1	–	–	﹤0.01%	4019
2026 Q1	$6	Hold	1	–	–	﹤0.01%	3895
2025 Q4	$35	Hold	1	–	–	﹤0.01%	3650
2025 Q3	$59	Hold	1	–	–	﹤0.01%	3665
2025 Q2	$60	Buy	+1	New	+$132	﹤0.01%	3680
2025 Q1	–	Hold	0	–	–	–	4063
2024 Q4	–	Hold	0	–	–	–	4036

Other funds holding GCTK

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

GIPW

Granite Islands Private Wealth Guilford, Connecticut $135M AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SBI Securities's GCTK Position: Q2 2026 in Review

SBI Securities held its GlucoTrack (GCTK) position steady in Q2 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #4019.

SBI Securities first reported a position in GCTK in Q2 2025 and has held it in 5 quarters since. The position peaked at $60 in Q2 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

SBI Securities held 1 share of GlucoTrack worth $3 as of Q2 2026.
SBI Securities left its GlucoTrack share count unchanged in Q2 2026.
GlucoTrack made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #4019 holding.
SBI Securities first reported a position in GlucoTrack in Q2 2025 and has held it in 5 quarters since.
SBI Securities's GlucoTrack position peaked at $60 in Q2 2025.
18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.